Product NDC: | 50419-340 |
Proprietary Name: | Ultravist |
Non Proprietary Name: | iopromide |
Active Ingredient(s): | 311.7 mg/mL & nbsp; iopromide |
Administration Route(s): | INTRA-ARTERIAL; INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 50419-340 |
Labeler Name: | Bayer HealthCare Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020220 |
Marketing Category: | NDA |
Start Marketing Date: | 20091230 |
Package NDC: | 50419-340-05 |
Package Description: | 10 VIAL, GLASS in 1 CARTON (50419-340-05) > 50 mL in 1 VIAL, GLASS |
NDC Code | 50419-340-05 |
Proprietary Name | Ultravist |
Package Description | 10 VIAL, GLASS in 1 CARTON (50419-340-05) > 50 mL in 1 VIAL, GLASS |
Product NDC | 50419-340 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | iopromide |
Dosage Form Name | INJECTION |
Route Name | INTRA-ARTERIAL; INTRAVENOUS |
Start Marketing Date | 20091230 |
Marketing Category Name | NDA |
Labeler Name | Bayer HealthCare Pharmaceuticals Inc. |
Substance Name | IOPROMIDE |
Strength Number | 311.7 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] |